Sincerus Pharmaceuticals Completes Financing With SWK To Support The Demand For Its Customized Dermatologic Medicines
- Wednesday, March 24, 2021, 7:19
- PR Newswire
- Add a comment
POMPANO BEACH, Fla., March 24, 2021 /PRNewswire/ — Sincerus Pharmaceuticals, the parent company of Prescriber’s Choice and Sincerus Florida, today announced the completion of a major new round of growth financing with SWK Holdings Corporation (Nasdaq: SWKH), representing what is by far…